CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US22529Y4089
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 6,000.00 USD |
| Gross profit | 3,806.00 USD |
| Operating income | -6.14 m USD |
| EBIT | -6.00 m USD |
| Net income | -6.00 m USD |
| Diluted EPS – continuing operations | -2.52 USD |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
More stocks
- Twin Vee PowerCats, Co. (VEEE)
- Aclarion, Inc. (ACON)
- Traws Pharma, Inc. (TRAW)
- Liminatus Pharma, Inc. (LIMN)
- OLB GROUP, INC. (OLB)
- SUIC Worldwide Holdings Ltd. (SUIC)
- Perfect Moment Ltd. (PMNT)
- Global Innovative Platforms Inc. (GIPL)
- GHST World Inc. (GHST)
- International Land Alliance Inc. (ILAL)
- Cyngn Inc. (CYN)
- Trevi Finanziaria Industriale SpA (TFIN.MI)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.